Teijin Ltd (3401):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Teijin Ltd (3401) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12139
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Teijin Ltd (Teijin) is a technology driven holding company offering solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It focuses on the manufacture and sale of aramid fiber, carbon fiber products, synthetic fiber, films, polyester films, resin products, chemical products, IT products, pharmaceuticals, medical devices and water purification systems. The company offers pharmaceuticals for treating bone and joint diseases, respiratory diseases, cardiovascular and metabolic diseases, infectious and other diseases. Teijin operates facilities in America, Europe, Asia and Japan. The company sells its products in Asia, America, and Europe. Teijin is headquartered in Osaka, Japan.

Teijin Ltd (3401) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Teijin Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Teijin Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Teijin Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Teijin Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Teijin Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Teijin Ltd, Medical Equipment, Deal Details 10
Asset Purchase 10
Teijin Pharma Acquires Rights of Neurostar TMS Device from Neuronetics 10
Partnerships 11
Teijin Enters into Licensing Agreement with Nativis 11
Teijin Pharma Enters into Distribution Agreement with SRETT 12
Teijin Pharma Enters into Co-Marketing Agreement with Taisho Toyama Pharma 13
Teijin Pharma Enters into Co-Development Agreement with Kaketsuken 14
Debt Offering 15
Teijin Raises USD169.42 Million in Public Offering of Bonds Due 2018 15
Teijin Raises USD169.42 Million in Public Offering of Bonds Due 2021 16
Acquisition 17
Teijin to Acquire Controlling Stake in MedTech Heart from Seeds Rocket 17
Teijin to Acquire 86% of Implantable Medical Product Company of Takiron 18
Teijin Acquires 50% Stake in Nakashima Medical 19
Teijin Ltd – Key Competitors 20
Teijin Ltd – Key Employees 21
Teijin Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 25
Recent Developments 26
Financial Announcements 26
May 09, 2018: Teijin: Consolidated Financial Statements Summary For the year ended March 31, 2018 26
May 09, 2017: Teijin Reports Revenue Of JPY741.3 Billion In Fiscal 2017 29
Feb 06, 2017: TEIJIN:Consolidated Financial Statements For Nine Months Ended December 31 2016 30
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Teijin Ltd, Medical Equipment, Key Facts, 2018 2
Teijin Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Teijin Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Teijin Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Teijin Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Teijin Ltd, Deals By Market, 2012 to YTD 2018 8
Teijin Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Teijin Pharma Acquires Rights of Neurostar TMS Device from Neuronetics 10
Teijin Enters into Licensing Agreement with Nativis 11
Teijin Pharma Enters into Distribution Agreement with SRETT 12
Teijin Pharma Enters into Co-Marketing Agreement with Taisho Toyama Pharma 13
Teijin Pharma Enters into Co-Development Agreement with Kaketsuken 14
Teijin Raises USD169.42 Million in Public Offering of Bonds Due 2018 15
Teijin Raises USD169.42 Million in Public Offering of Bonds Due 2021 16
Teijin to Acquire Controlling Stake in MedTech Heart from Seeds Rocket 17
Teijin to Acquire 86% of Implantable Medical Product Company of Takiron 18
Teijin Acquires 50% Stake in Nakashima Medical 19
Teijin Ltd, Key Competitors 20
Teijin Ltd, Key Employees 21
Teijin Ltd, Other Locations 23
Teijin Ltd, Subsidiaries 23
Teijin Ltd, Joint Venture 25

List of Figures
Teijin Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Teijin Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Teijin Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Teijin Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Teijin Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Teijin Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Teijin Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Teijin Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Teijin Ltd (3401):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cummins Inc (CMI)-エネルギー分野:企業M&A・提携分析
    Summary Cummins Inc. (Cummins) is a manufacturer of diesel engines and related technologies. It designs, manufactures, services and distributes engines and related component solutions. The company offers filtration, fuel systems, control systems, after treatment devices, turbochargers, air handling …
  • Ipsen SA (IPN):企業の財務・戦略的SWOT分析
    Ipsen SA (IPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Companhia Energetica de Sao Paulo (CESP6):企業の財務・戦略的SWOT分析
    Companhia Energetica de Sao Paulo (CESP6) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Opiant Pharmaceuticals Inc (OPNT):医療機器:M&Aディール及び事業提携情報
    Summary Opiant Pharmaceuticals Inc (Opiant), formerly, Lightlake Therapeutics Inc is a specialty pharmaceutical company that develops pharmacological treatments for substance use, addiction and eating disorders. It focuses on developing treatments to reverse opioid overdoses, for overweight and obes …
  • Vancive Medical Technologies:医療機器:M&Aディール及び事業提携情報
    Summary Vancive Medical Technologies (Vancive) is a medical technology company with expertise in adhesive chemistries and medical technologies focused on pressure-sensitive adhesives for medical applications. The company provides product portfolio such as medical adhesive tapes, negative pressure wo …
  • Chimei Innolux Corporation (3481):企業の財務・戦略的SWOT分析
    Chimei Innolux Corporation (3481) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Superior Energy Services Inc (SPN):石油・ガス:M&Aディール及び事業提携情報
    Summary Superior Energy Services Inc (Superior Energy) is a provider of equipment and production services to the energy industry. It offers drilling, completion and production-related services to independent oil and gas companies. The company also manufactures, rent and sell specialized tools and eq …
  • DCP Midstream, LP:企業の戦略・SWOT・財務分析
    DCP Midstream, LP - Strategy, SWOT and Corporate Finance Report Summary DCP Midstream, LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • SynDevRx Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SynDevRx Inc (SDX) is a drug development company that develops treatments for cancer and metabolic dysfunction. The company offers lead compound SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active novel small molecule fumagillol derivative in vivo. Its servic …
  • ATCC:製薬・医療:M&Aディール及び事業提携情報
    Summary ATCC is a nonprofit bioresource center and research organization that provides biological products, technical services and educational programs. The organization acquires, preserves, develops, authenticates, produces, and distributes standard reference microorganisms, cell lines and other ma …
  • PTC Inc (PTC):企業の財務・戦略的SWOT分析
    PTC Inc (PTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Swiss AviationSoftware Ltd.:企業の戦略的SWOT分析
    Swiss AviationSoftware Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • ObsEva SA (OBSV):製薬・医療:M&Aディール及び事業提携情報
    Summary ObsEva SA (ObsEva) is a clinical-stage biopharmaceutical company that develops and commercializes drugs for women’s reproductive health and pregnancy. The company's product portfolio comprises pipeline products which is being developed to control preterm labor by reducing inflammation, decre …
  • China Power Clean Energy Development Co Ltd (0735):企業の財務・戦略的SWOT分析
    China Power Clean Energy Development Co Ltd (0735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Gulfsands Petroleum plc (GPX):企業の財務・戦略的SWOT分析
    Summary Gulfsands Petroleum plc (Gulfsands) is an oil and gas company that offers exploration, development, and production services. The company carries out acquisition, exploration, develops, and produces oil and natural gas. It holds interests in oil exploration and development projects in the Syr …
  • MicroPort Scientific Corp (853):企業の財務・戦略的SWOT分析
    Summary MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co Ltd is a medical device company which develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, e …
  • Star Group LP (SGU):企業の財務・戦略的SWOT分析
    Summary Star Group LP (Star Group) formerly Star Gas Partners LP, is a distributor of home heating products and services. The company distributes and sells heating and air conditioning equipment, diesel fuel, gasoline, propane, and home heating oil. Star Group offers home security and plumbing, inst …
  • Dedeman Hotels & Resorts International:企業の戦略・SWOT・財務分析
    Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report Summary Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Neuwave Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary NeuWave Medical Inc (NeuWave Medical), a subsidiary of Ethicon US LLC is a medical device company that develops and commercializes energy-based minimally invasive medical devices. The company’s product Certus 140 microwave ablation (coagulation) system is a minimally invasive soft tissue abl …
  • JG Summit Holdings Inc:戦略・SWOT・企業財務分析
    JG Summit Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary JG Summit Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆